USANA Health Sciences (NYSE:USNA) Director Gilbert Fuller Sells 1,057 Shares

USANA Health Sciences, Inc. (NYSE:USNA) Director Gilbert Fuller sold 1,057 shares of the business’s stock in a transaction on Friday, May 22nd. The stock was sold at an average price of $18.66, for a total value of $19,723.62. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink.

USANA Health Sciences Stock Down 3.5%

USNA stock traded down $0.66 during trading on Tuesday, reaching $18.08. 29,553 shares of the company’s stock were exchanged, compared to its average volume of 125,315. USANA Health Sciences, Inc. has a 1-year low of $16.60 and a 1-year high of $38.32. The company’s fifty day moving average price is $18.22 and its 200-day moving average price is $19.49. The firm has a market cap of $333.76 million, a PE ratio of 38.47, a P/E/G ratio of 0.74 and a beta of 0.77.

USANA Health Sciences (NYSE:USNA) last posted its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, topping analysts’ consensus estimates of $0.44 by $0.17. USANA Health Sciences had a return on equity of 6.21% and a net margin of 0.96%.The company had revenue of $250.22 million for the quarter, compared to the consensus estimate of $240.99 million. USANA Health Sciences has set its FY 2026 guidance at 1.950-2.290 EPS. As a group, sell-side analysts expect that USANA Health Sciences, Inc. will post 2.12 earnings per share for the current fiscal year.

Hedge Funds Weigh In On USANA Health Sciences

A number of hedge funds have recently modified their holdings of USNA. National Bank of Canada FI grew its holdings in shares of USANA Health Sciences by 166.6% in the 3rd quarter. National Bank of Canada FI now owns 1,922 shares of the company’s stock worth $53,000 after acquiring an additional 1,201 shares during the last quarter. State of Wyoming acquired a new position in shares of USANA Health Sciences in the 1st quarter worth $57,000. Tower Research Capital LLC TRC grew its holdings in shares of USANA Health Sciences by 382.5% in the 2nd quarter. Tower Research Capital LLC TRC now owns 2,398 shares of the company’s stock worth $73,000 after acquiring an additional 1,901 shares during the last quarter. Parallel Advisors LLC grew its holdings in shares of USANA Health Sciences by 1,354.3% in the 4th quarter. Parallel Advisors LLC now owns 3,854 shares of the company’s stock worth $76,000 after acquiring an additional 3,589 shares during the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank lifted its stake in USANA Health Sciences by 52.9% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,834 shares of the company’s stock valued at $106,000 after buying an additional 1,327 shares in the last quarter. 54.25% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research firms have recently commented on USNA. Weiss Ratings reissued a “sell (d)” rating on shares of USANA Health Sciences in a research note on Friday, March 27th. Zacks Research downgraded USANA Health Sciences from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, April 22nd. Finally, Wall Street Zen downgraded USANA Health Sciences from a “buy” rating to a “hold” rating in a research note on Saturday, May 2nd. One equities research analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, USANA Health Sciences has an average rating of “Reduce”.

About USANA Health Sciences

USANA Health Sciences, Inc is a Utah‐based company that develops, manufactures and distributes nutritional supplements and personal care products through a network of independent distributors. Founded in 1992 by Dr. Myron Wentz, the company’s portfolio includes vitamins, minerals, dietary supplements, weight‐management products and skin‐care formulations. USANA’s products are formulated in its own laboratories to meet pharmaceutical‐grade standards, and the company has invested heavily in research and development and quality control to support its offerings.

Operating primarily through a direct selling model, USANA serves markets in North America, Asia Pacific, Europe and Latin America.